These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 30940659)
1. Antagonism between HTRA3 and TGFβ1 Contributes to Metastasis in Non-Small Cell Lung Cancer. Zhao J; Feng M; Liu D; Liu H; Shi M; Zhang J; Qu J Cancer Res; 2019 Jun; 79(11):2853-2864. PubMed ID: 30940659 [TBL] [Abstract][Full Text] [Related]
2. miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells. Li X; Han J; Zhu H; Peng L; Chen Z Int J Oncol; 2017 Jul; 51(1):158-168. PubMed ID: 28534939 [TBL] [Abstract][Full Text] [Related]
3. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma. Han Y; Tian H; Chen P; Lin Q Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994 [TBL] [Abstract][Full Text] [Related]
4. TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer. Vázquez PF; Carlini MJ; Daroqui MC; Colombo L; Dalurzo ML; Smith DE; Grasselli J; Pallotta MG; Ehrlich M; Bal de Kier Joffé ED; Puricelli L Clin Exp Metastasis; 2013 Dec; 30(8):993-1007. PubMed ID: 23832740 [TBL] [Abstract][Full Text] [Related]
5. miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC. Xiao G; Gao X; Sun X; Yang C; Zhang B; Sun R; Huang G; Li X; Liu J; Du N; Liu D; Liang R; Ren H; Qin S Oncol Rep; 2017 Aug; 38(2):1190-1198. PubMed ID: 28656290 [TBL] [Abstract][Full Text] [Related]
6. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer. Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of Nemo‑like kinase promotes metastasis in non‑small‑cell lung cancer. Shi C; Xu L; Tang Z; Zhang W; Wei Y; Ni J; Zhang S; Feng J Oncol Rep; 2019 Sep; 42(3):1090-1100. PubMed ID: 31322229 [TBL] [Abstract][Full Text] [Related]
8. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207 [TBL] [Abstract][Full Text] [Related]
10. The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling. Lu Z; Li Y; Che Y; Huang J; Sun S; Mao S; Lei Y; Li N; Sun N; He J Cancer Lett; 2018 Sep; 432():156-168. PubMed ID: 29908210 [TBL] [Abstract][Full Text] [Related]
11. VEGFC/VEGFR3 axis mediates TGFβ1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cells. Duan L; Ye L; Zhuang L; Zou X; Liu S; Zhang Y; Zhang L; Jin C; Huang Y PLoS One; 2018; 13(7):e0200452. PubMed ID: 29995950 [TBL] [Abstract][Full Text] [Related]
12. High temperature requirement A3 (HTRA3) expression predicts postoperative recurrence and survival in patients with non-small-cell lung cancer. Zhao J; Zhang J; Zhang X; Feng M; Qu J Oncotarget; 2016 Jun; 7(26):40725-40734. PubMed ID: 27166271 [TBL] [Abstract][Full Text] [Related]
13. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer. Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion. Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in human non-small cell lung cancer. Zhang JX; Zhai JF; Yang XT; Wang J Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3793-3801. PubMed ID: 27735039 [TBL] [Abstract][Full Text] [Related]
16. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche. Castañón E; Soltermann A; López I; Román M; Ecay M; Collantes M; Redrado M; Baraibar I; López-Picazo JM; Rolfo C; Vidal-Vanaclocha F; Raez L; Weder W; Calvo A; Gil-Bazo I Cancer Lett; 2017 Aug; 402():43-51. PubMed ID: 28549790 [TBL] [Abstract][Full Text] [Related]
17. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer. Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545 [TBL] [Abstract][Full Text] [Related]
18. Neuropilin 1 modulates TGF‑β1‑induced epithelial‑mesenchymal transition in non‑small cell lung cancer. Ding Z; Du W; Lei Z; Zhang Y; Zhu J; Zeng Y; Wang S; Zheng Y; Liu Z; Huang JA Int J Oncol; 2020 Feb; 56(2):531-543. PubMed ID: 31894269 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
20. Activation of PPARγ in Myeloid Cells Promotes Progression of Epithelial Lung Tumors through TGFβ1. Sippel TR; Johnson AM; Li HY; Hanson D; Nguyen TT; Bullock BL; Poczobutt JM; Kwak JW; Kleczko EK; Weiser-Evans MC; Nemenoff RA Mol Cancer Res; 2019 Aug; 17(8):1748-1758. PubMed ID: 31088909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]